SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

13 Nov 2024 Evaluate
A decrease in the sales to Rs. 419.90 millions was observed for the quarter ended September 2024. The sales stood at Rs. 491.20 millions during the similar quarter previous year.The Total Profit for the quarter ended September 2024 of Rs. 42.60 millions grew from Rs.-9.20 millionsThe company reported a good operating profit of 138.50 millions compared to 21.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 419.90 491.20 -14.52 996.60 895.40 11.30 1685.18 2226.85 -24.32
Other Income 159.50 98.70 61.60 267.90 195.70 36.89 459.80 282.42 62.81
PBIDT 138.50 21.60 541.20 227.10 27.90 713.98 193.16 18.82 926.35
Interest 10.00 12.10 -17.36 18.10 21.90 -17.35 43.61 25.13 73.54
PBDT 85.30 9.50 797.89 165.80 -56.50 -393.45 87.01 -6.31 -1478.92
Depreciation 21.20 23.50 -9.79 41.20 47.80 -13.81 89.40 91.15 -1.92
PBT 64.10 -14.00 -557.86 124.60 -104.30 -219.46 -2.39 -97.46 -97.55
TAX 21.50 -4.80 -547.92 37.00 -27.10 -236.53 -8.61 -36.66 -76.51
Deferred Tax 10.80 -19.80 -154.55 16.60 -27.10 -161.25 -13.20 -30.94 -57.34
PAT 42.60 -9.20 -563.04 87.60 -77.20 -213.47 6.22 -60.80 -110.23
Equity 499.20 498.90 0.06 499.20 498.90 0.06 498.86 498.86 0.00
PBIDTM(%) 32.98 4.40 650.08 22.79 3.12 631.33 11.46 0.85 1256.32

Viyash Scientific Share Price

208.35 1.05 (0.51%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×